Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2124 A Case Report of a Malignant Insulinoma
Introduction: Despite rare (1-2% of pancreatic tumors/PT), insulinomas are the most common functional pNET. The diagnosis is established by demonstrating inappropriately high serum insulin levels during a spontaneous or induced episode of hypoglycemia.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Zoumblios C, Tegos T, Kyriakopoulos G, Argyrakos T, Alevizopoulos N,
Keywords: malignant, insulinoma,
Introduction: In metastatic NET G1-G2 progressed after SSA, many treatment are appropriated including EV, CT and PRRT. However, there are no studies guiding the appropriate sequence of treatments.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Marconcini R
Authors: Marconcini R, Ricci S, Antonuzzo A, Luca G, Vasile E,
Keywords: everolimus SSA,
Introduction: Oxaliplatine plus fluoropirimidine and capecitabine treatment alone are considered investigational treatments in well-differentiated (WD) NET
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Marconcini R
Authors: Marconcini R, Ricci S, Galli L, Antonuzzo A, Vasile E,
Keywords: capecitabine, oxaliplatine ,
Introduction: Alkylating agents are the backbone chemotherapy in neuroendocrine tumors (NET). However, gemcitabine associated to oxaliplatine (gemox) has showed interesting activity in a small study.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Dussol A, Joly M, Hervieu V, Forestier J, Lombard-Bohas C,
Keywords: gemox, alkylating agent, MGMT,